4//SEC Filing
Pulse Biosciences, Inc. 4
Accession 0001209191-17-031389
$PLSECIK 0001625101operating
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:58 PM ET
Size
9.0 KB
Accession
0001209191-17-031389
Insider Transaction Report
Form 4
Thaure Thierry B.
Director
Transactions
- Exercise/Conversion
Common Stock
2017-05-08$2.67/sh+15,000$40,050→ 15,000 total - Sale
Common Stock
2017-05-08$22.49/sh−15,000$337,320→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2017-05-08−15,000→ 60,655 totalExercise: $2.67Exp: 2020-06-01→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]This is the weighted average purchase price of the shares, which ranged from $22.00 to $23.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- [F2]The shares subject to the option will vest in equal quarterly installments over a three year period commencing on June 1, 2015 and ending on March 1, 2018, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Pulse Biosciences, Inc.
CIK 0001625101
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001625101
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 5:58 PM ET
- Size
- 9.0 KB